These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1458553)

  • 1. Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.
    Dorr RT; Shipp NG; Liddil JD; Iyengar BS; Kunz KR; Remers WA
    Cancer Chemother Pharmacol; 1992; 31(1):1-5. PubMed ID: 1458553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY 25282 and BMY 25067, in isolated rat hepatocytes.
    Silva JM; Khan S; O'Brien PJ
    Biochem Pharmacol; 1993 Jun; 45(11):2303-9. PubMed ID: 8517871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro.
    Dorr RT; Shipp NG; Lee KM
    Anticancer Drugs; 1991 Feb; 2(1):27-33. PubMed ID: 1958848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between doxorubicin and mitomycin C on mortality and myocardial contractility in guinea pig.
    Monti E; Bossa R; Galatulas I; Favalli L; Villani F; Piccinini F
    Tumori; 1983 Apr; 69(2):113-6. PubMed ID: 6407163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac, renal, and pulmonary toxicity of several mitomycin derivatives in rats.
    Bregman CL; Buroker RA; Bradner WT; Hirth RS; Madissoo H
    Fundam Appl Toxicol; 1989 Jul; 13(1):46-64. PubMed ID: 2767361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
    Bradner WT; Rose WC; Schurig JE; Florczyk AP
    Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551).
    Bradner WT; Catino JJ; Long BH; Rose WC; Schurig JE
    Anticancer Res; 1992; 12(3):959-64. PubMed ID: 1622154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
    Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic involvement in adriamycin cardiotoxicity.
    Seraydarian MW; Artaza L; Yang JJ
    Adv Myocardiol; 1980; 2():213-23. PubMed ID: 7423039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
    Shipp NG; Dorr RT; Alberts DS; Dawson BV; Hendrix M
    Cancer Res; 1993 Feb; 53(3):550-6. PubMed ID: 8425187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines.
    Ghiorghis A; Talebian A; Clarke R
    Cancer Chemother Pharmacol; 1992; 29(4):290-6. PubMed ID: 1537075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-radical formation by mitomycin C and its novel analogs in cardiac microsomes and the perfused rat heart.
    Politi PM; Rajagopalan S; Sinha BK
    Biochim Biophys Acta; 1989 Sep; 992(3):341-8. PubMed ID: 2550081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of 7-N-(2-((2-(-gamma-L-glutamylamino)- ethyl)dithio)ethyl)-mitomycin C and metabolites in cell lines with different resistance patterns.
    Dirix LY; Gheuens EE; van der Heyden S; van Oosterom AT; De Bruijn EA
    Anticancer Drugs; 1994 Jun; 5(3):343-54. PubMed ID: 7919460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of mitomycin C-induced multidrug resistance in vitro.
    Dorr RT; Liddil JD
    Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
    Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose and multiple-dose intravenous toxicity studies of BMY-25282 in rats.
    Bregman CL; Comereski CR; Buroker RA; Hirth RS; Madissoo H; Hottendorf GH
    Fundam Appl Toxicol; 1987 Jul; 9(1):90-109. PubMed ID: 3622965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C.
    Kawasaki S; Akiyama S; Kurokawa T; Kataoka M; Dohmitsu K; Kondoh K; Yamauchi M; Ito K; Watanabe T; Sugiyama S
    Jpn J Cancer Res; 1992 Aug; 83(8):899-906. PubMed ID: 1399827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin antibiotic reductive potential and related pharmacological activities.
    Pan SS; Gonzalez H
    Mol Pharmacol; 1990 Jun; 37(6):966-70. PubMed ID: 2113607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.